HIMS → $30.00 by Jun 5, 2026.

# TL;DR: HIMS management intentionally sandbagged their Q4 earnings guidance to crash the stock to $13.74, authorized a $250M buyback to scoop up shares on the cheap, let the market price in a Novo Nordisk regulatory death knell, and then dropped a nuclear bomb on Friday: They settled the lawsuit with Novo Nordisk and are partnering to sell Wegovy. This isn't a memestock play; this is a multi-billion dollar valuation arbitrage engineered by a CEO who just outplayed Wall Street. …